Carbon monoxide prevents hypertension and proteinuria in an adenovirus sFlt-1 preeclampsia-like mouse model.

PubWeight™: 0.86‹?›

🔗 View Article (PMC 4159267)

Published in PLoS One on September 09, 2014

Authors

Carolina C Venditti1, Richard Casselman1, Iain Young2, S Ananth Karumanchi3, Graeme N Smith4

Author Affiliations

1: Department of Biomedical and Molecular Science, Queen's University, Kingston, Canada.
2: Department of Health Sciences, Queen's University, Kingston, Canada.
3: Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
4: Department of Biomedical and Molecular Science, Queen's University, Kingston, Canada; Department of Obstetrics and Gynecology, Kingston General Hospital, Kingston, Canada.

Articles citing this

Exposure to experimental preeclampsia in mice enhances the vascular response to future injury. Hypertension (2015) 0.92

Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia. Biochem Pharmacol (2015) 0.92

Soluble fms-like tyrosine kinase 1 promotes angiotensin II sensitivity in preeclampsia. J Clin Invest (2016) 0.80

Heme oxygenase-1 is critically involved in placentation, spiral artery remodeling, and blood pressure regulation during murine pregnancy. Front Pharmacol (2015) 0.79

Deconstructing the smoking-preeclampsia paradox through a counterfactual framework. Eur J Epidemiol (2016) 0.78

Classical Complement Pathway Activation in the Kidneys of Women With Preeclampsia. Hypertension (2015) 0.78

Biomarker development for presymptomatic molecular diagnosis of preeclampsia: feasible, useful or even unnecessary? Expert Rev Mol Diagn (2015) 0.77

PAD4 Deficiency Decreases Inflammation and Susceptibility to Pregnancy Loss in a Mouse Model. Biol Reprod (2016) 0.75

First-trimester smoking cessation in pregnancy did not increase the risk of preeclampsia/eclampsia: A Murmansk County Birth Registry study. PLoS One (2017) 0.75

Personalized Therapy Against Preeclampsia by Replenishing Placental Protein 13 (PP13) Targeted to Patients With Impaired PP13 Molecule or Function. Comput Struct Biotechnol J (2017) 0.75

Resolution of inflammation pathways in preeclampsia-a narrative review. Immunol Res (2017) 0.75

Articles cited by this

A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology (1973) 127.36

Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med (2004) 14.00

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest (2003) 13.72

Pre-eclampsia. Lancet (2005) 10.41

The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol (1997) 7.50

Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol (1989) 5.73

From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Diabetes (2005) 3.10

Cigarette smoking during pregnancy and risk of preeclampsia: a systematic review. Am J Obstet Gynecol (1999) 2.79

Carbon monoxide: endogenous production, physiological functions, and pharmacological applications. Pharmacol Rev (2005) 2.73

Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia. Hypertension (2007) 2.62

Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertension (2005) 2.22

Vascular endothelial growth factor receptor-1 (VEGFR-1/Flt-1): a dual regulator for angiogenesis. Angiogenesis (2006) 1.97

Heme oxygenase-1 gene expression modulates angiotensin II-induced increase in blood pressure. Hypertension (2004) 1.87

Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction. Microcirculation (2002) 1.78

The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice. Am J Obstet Gynecol (2007) 1.65

Maternal exposure to moderate ambient carbon monoxide is associated with decreased risk of preeclampsia. Am J Obstet Gynecol (2012) 1.56

Adverse pregnancy outcomes in snuff users. Am J Obstet Gynecol (2003) 1.48

Human heme oxygenase-1 gene transfer lowers blood pressure and promotes growth in spontaneously hypertensive rats. Hypertension (2001) 1.48

Increase in heme oxygenase-1 levels ameliorates renovascular hypertension. Kidney Int (2005) 1.48

Smoking and risk of preeclampsia: a systematic review. Front Biosci (2007) 1.47

Glomerular capillary endotheliosis in toxemia of pregnancy. Arch Pathol (1959) 1.42

Amniotic fluid--soluble vascular endothelial growth factor receptor-1 in preeclampsia. Obstet Gynecol (2000) 1.39

Tobacco use during pregnancy and preeclampsia risk: effects of cigarette smoking and snuff. Hypertension (2010) 1.28

Reduction of circulating soluble Flt-1 alleviates preeclampsia-like symptoms in a mouse model. J Cell Mol Med (2009) 1.24

Effect of recombinant placental growth factor 2 on hypertension induced by full-length mouse soluble fms-like tyrosine kinase 1 adenoviral vector in pregnant mice. Hypertension (2009) 1.19

Human placental syncytiotrophoblast microvillous membranes impair maternal vascular endothelial function. Br J Obstet Gynaecol (1997) 1.16

Gene expression in chorionic villous samples at 11 weeks' gestation from women destined to develop preeclampsia. Prenat Diagn (2008) 1.14

Bilirubin attenuates radical-mediated damage to serum albumin. FEBS Lett (1993) 1.08

Direct placental effects of cigarette smoke protect women from pre-eclampsia: the specific roles of carbon monoxide and antioxidant systems in the placenta. Med Hypotheses (2005) 1.06

Physiological significance of heme oxygenase in hypertension. Int J Biochem Cell Biol (2008) 1.04

HO in pregnancy. Free Radic Biol Med (2005) 0.99

Carbon monoxide inhibits hypoxia/reoxygenation-induced apoptosis and secondary necrosis in syncytiotrophoblast. Am J Pathol (2006) 0.98

Induction of heme oxygenase-1 attenuates sFlt-1-induced hypertension in pregnant rats. Am J Physiol Regul Integr Comp Physiol (2011) 0.96

Carbon monoxide decreases perfusion pressure in isolated human placenta. Placenta (2002) 0.95

Preeclampsia: the endothelium, circulating factor(s) and vascular endothelial growth factor. J Soc Gynecol Investig (1999) 0.92

Protection from abortion by heme oxygenase-1 up-regulation is associated with increased levels of Bag-1 and neuropilin-1 at the fetal-maternal interface. J Immunol (2005) 0.91

Heme Oxygenase-1 Attenuates Hypoxia-Induced sFlt-1 and Oxidative Stress in Placental Villi through Its Metabolic Products CO and Bilirubin. Int J Hypertens (2011) 0.91

End tidal carbon monoxide levels are lower in women with gestational hypertension and pre-eclampsia. J Perinatol (2004) 0.91

Effect of Croatian propolis on diabetic nephropathy and liver toxicity in mice. BMC Complement Altern Med (2012) 0.91

End-tidal carbon monoxide measurements in women with pregnancy-induced hypertension and preeclampsia. Am J Obstet Gynecol (2000) 0.87

Exploring the potential of low doses carbon monoxide as therapy in pregnancy complications. Med Gas Res (2012) 0.83

Chronic carbon monoxide inhalation during pregnancy augments uterine artery blood flow and uteroplacental vascular growth in mice. Am J Physiol Regul Integr Comp Physiol (2013) 0.81

Endothelial growth factor therapy improves preeclampsia-like manifestations in a murine model induced by overexpression of sVEGFR-1. Am J Physiol Heart Circ Physiol (2011) 0.79

Effects of chronic carbon monoxide exposure on fetal growth and development in mice. BMC Pregnancy Childbirth (2011) 0.76